Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

Completed · Phase 2 · Has a placebo group

Conditions studied: Bronchiectasis

In brief

The purpose of this study is to find out if bacterial load in the airways can be reduced after inhalation of ciprofloxacin for 28 days.

Key facts

Study ID

NCT00930982

Run by

Bayer

People needed

124

Starts

2009-06-01

Expected to finish

2010-09-01

Last updated by the study team

2014-12-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a proven and documented diagnosis of non-cystic fibrosis idiopathic or post pneumonic bronchiectasis
• Stable pulmonary status and stable regimen of standard treatment at least for the past 30 days

You may not qualify if…

• Forced Expiratory Volume 1 < 35% or > 80%
• Allergic bronchopulmonary aspergillosis
• Immunodeficiency disease requiring immunoglobulin replacement
• Inflammatory bowel disease

Where it is running

• Study site — Witten, North Rhine-Westphalia, Germany
• Study site — Koblenz, Rhineland-Palatinate, Germany
• Study site — Mainz, Rhineland-Palatinate, Germany
• Study site — Geesthacht, Schleswig-Holstein, Germany
• Study site — Großhansdorf, Schleswig-Holstein, Germany
• Study site — Berlin, State of Berlin, Germany
• Study site — Berlin, State of Berlin, Germany
• Study site — Berlin, State of Berlin, Germany
• Study site — Berlin, State of Berlin, Germany
• Study site — Bad Berka, Thuringia, Germany
• Study site — Santiago de Compostela, A Coruña, Spain
• Study site — Badajoz, Badajoz, Spain
• Study site — Barcelona, Barcelona, Spain
• Study site — Palma de Mallorca, Illes Baleares, Spain
• Study site — Uppsala, Sweden
• Study site — Bristol, Avon, United Kingdom
• Study site — Cambridge, Cambridgeshire, United Kingdom
• Study site — Liverpool, Merseyside, United Kingdom
• Study site — Belfast, North Ireland, United Kingdom
• Study site — Newcastle upon Tyne, Tyne and Wear, United Kingdom
• Study site — Edinburgh, United Kingdom
• Study site — Norwich, United Kingdom
• Study site — Little Rock, Arkansas, United States
• Study site — La Jolla, California, United States
• Study site — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.